Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanta Subbarao

Showing results (271-280 of 300) with videos related to

Pageof 30
Sort By:
Iscience|February 27, 2023
Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variantsIsabelle Montgomerie, Thomas W Bird, Olga R Palmer, et al.
Frontiers in Immunology|August 15, 2022
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
The Journal of Experimental Medicine|June 14, 2017
Recurrent rhinovirus infections in a child with inherited MDA5 deficiencyIan T Lamborn, Huie Jing, Yu Zhang, et al.
Annals of the New York Academy of Sciences|February 1, 2023
Respiratory viruses: New frontiers-a Keystone Symposia reportJennifer Cable, Jie Sun, In Su Cheon, et al.
Vaccine|October 30, 2023
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccinesYi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.
Nature Communications|July 29, 2015
Evaluation of candidate vaccine approaches for MERS-CoVLingshu Wang, Wei Shi, M Gordon Joyce, et al.
NPJ Vaccines|January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Biorxiv : the Preprint Server for Biology|September 29, 2022
Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2Rajeev Rudraraju, Matthew J Gartner, Jessica A Neil, et al.
Stem Cell Reports|June 14, 2023
Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatmentRajeev Rudraraju, Matthew J Gartner, Jessica A Neil, et al.
The Journal of Experimental Medicine|January 12, 2011
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionJens Wrammert, Dimitrios Koutsonanos, Gui-Mei Li, et al.
Pageof 30

Showing results (271-280 of 300) with videos related to

Sort By:
Pageof 30
Iscience|February 27, 2023
Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variantsIsabelle Montgomerie, Thomas W Bird, Olga R Palmer, et al.
Frontiers in Immunology|August 15, 2022
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
The Journal of Experimental Medicine|June 14, 2017
Recurrent rhinovirus infections in a child with inherited MDA5 deficiencyIan T Lamborn, Huie Jing, Yu Zhang, et al.
Annals of the New York Academy of Sciences|February 1, 2023
Respiratory viruses: New frontiers-a Keystone Symposia reportJennifer Cable, Jie Sun, In Su Cheon, et al.
Vaccine|October 30, 2023
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccinesYi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.
Nature Communications|July 29, 2015
Evaluation of candidate vaccine approaches for MERS-CoVLingshu Wang, Wei Shi, M Gordon Joyce, et al.
NPJ Vaccines|January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Biorxiv : the Preprint Server for Biology|September 29, 2022
Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2Rajeev Rudraraju, Matthew J Gartner, Jessica A Neil, et al.
Stem Cell Reports|June 14, 2023
Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatmentRajeev Rudraraju, Matthew J Gartner, Jessica A Neil, et al.
The Journal of Experimental Medicine|January 12, 2011
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionJens Wrammert, Dimitrios Koutsonanos, Gui-Mei Li, et al.
Pageof 30